Company / Cash per Share
MADRIGAL PHARMACEUTICALS, INC. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$9.03
FY2025
5-year range
$2.34 / $19.35
FY2021-FY2025
Trend
+79.4%
vs FY2024
Sector context
#22 of 205
Health Care
What the data says
MADRIGAL PHARMACEUTICALS, INC.'s cash per share of $9.03 is higher than 89% of companies in the Health Care sector (FY2025). Cash per Share returned to growth in FY2025 after 2 years of decline, reaching $9.03.
Based on SEC 10-K filings.
9.03 in FY2025 with a 5-year CAGR of +20.9%. Top quartile in the Health Care sector.
Improved from $5.52 to $9.03 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -22.4%
- 5-Year CAGR
- +20.9%
- 10-Year CAGR
- -
Sector benchmark
Top 11% in Health CareTop 11% of 205This company $9.03 Sector average $72.93
▼
-87.6% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 79.4% year-over-year.
- Ranks #22 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2022.
- Lowest cash per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.03 | +79.4% |
| FY2024 | $5.03 | -8.8% |
| FY2023 | $5.52 | -71.5% |
| FY2022 | $19.35 | +727.2% |
| FY2021 | $2.34 | -33.2% |
| FY2020 | $3.50 | +15.4% |
| FY2019 | $3.03 | -21.8% |
| FY2018 | $3.88 | -68.1% |
| FY2017 | $12.14 | +230.0% |
| FY2016 | $3.68 | +211645.5% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026